Quarterly report [Sections 13 or 15(d)]

Investment in account receivable (Details Narrative)

v3.25.1
Investment in account receivable (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Feb. 15, 2022
Apr. 10, 2015
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2024
Jun. 11, 2024
Oct. 14, 2023
Sep. 30, 2023
Jan. 10, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Warrants price per share     $ 0.62         $ 0.64        
Warrants redemption price     $ 0.10                  
Impairment of investments             $ 139,148          
Gain on investments $ 41,930                      
Annual installment payments                       $ 117,000
Due in 2024                       117,000
Due in 2025                       117,000
Due in 2026                       $ 117,000
Impairment     $ (250,208)         $ (250,208) $ 250,208      
Face value     287,200 [1]         287,200 [1] 287,200      
Unamortized discount     36,992         $ 36,992 $ 36,992      
Amortization of debt discount     $ 0 $ 4,751                
Other Income [Member]                        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Gain on investments $ 41,930       $ 41,930 $ 22,718            
Series D Warrants [Member]                        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Warrants price per share     $ 0.02             $ 0.02 $ 1.60  
Exchange Agreement [Member]                        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Account receivable with annual installment payments   $ 117,000                    
Annual installment receivable, term   11 years                    
Shares issued, value   $ 1,287,000                    
Shares issued, shares   757,059                    
Investment in account receivable discount percent     17.87%                  
Share price     $ 0.78                  
Exchange Agreement [Member] | Series D Warrants [Member]                        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Warrants issued   757,059                    
Warrants price per share   $ 1.60                    
Warrants redemption price   $ 0.10                    
[1] Coincident with the June 11, 2024 impairment, accounts receivable of $2,300 were reclassed and concurrently impaired. Prior to the full impairment, the Company reduced the face value of its investment in account receivable by an additional $100 per month for five receivable payment installments.